Somerset, NJ – August 9, 2016 – LabVantage Solutions has extended its partnership with Lonza to offer purpose-built environmental monitoring capabilities integrated with LIMS. This combined solution is the only one in the market today that provides comprehensive environment monitoring capabilities integrated with an enterprise-grade LIMS to provide the Life Sciences industry with a unified microbiology and analytical solution that is unparalleled.
LabVantage®offers a market-leading LIMS based on 35+ years of experience in the Laboratory Informatics space. LabVantage provides a highly configurable, web-based LIMS that powers hundreds of laboratories globally, large and small, spanning industries such as pharmaceutical, biotech, food and beverage, chemicals, oil and gas, consumer packaged goods and more. Lonza’s MODA-EM®purpose-built environmental monitoring solution for quality control microbiology provides a mobile computing platform for the paperless collection, processing, and tracking of environmental monitoring and utility samples. The MODA-EM®solution offers best- in-class visualization with an extensive library of pre-built reports and charts. LabVantage has been an exclusive partner of Lonza since 2007, and both companies have been working together to provide customers with the most advanced environmental monitoring capabilities in the market.
With LabVantage 8, LabVantage has introduced the MODA®Connector, the only commercially available off-the-shelf LIMS interface to the MODA-EM® solution. LabVantage, when implemented together with Lonza’s MODA-EM®solution and the LabVantage MODA®Connector, enables seamless exchange of data between the two systems providing increased operational efficiency, improved quality, and reduced cost. The MODA®Connector uses a standard web-services based interface to provide bi-directional exchange of testing requests and micro results between the two systems. The interface also provides LIMS users with visibility into any environmental monitoring deviations during the manufacturing process ensuring product quality during lot release. LabVantage is the only company in the market today that offers a LIMS solution pre-integrated with the MODA-EM®platform
“We are excited to extend our partnership with Lonza to offer our customers best-in-class environmental monitoring capabilities” said Bob Voelkner, Manager, Strategic Accounts at LabVantage. “The ability to integrate the environmental monitoring workflow across LIMS and MODA-EM® provides customers with the most comprehensive, end-to-end monitoring capabilities in the market” he continued.
“Lonza and LabVantage represent best-in-class applications for microbiology and analytical quality control. The integrated MODA-EM®and LabVantage 8 product suite provide customers with unparalleled functionality and capabilities for a comprehensive product lot release data set,” said Richard Kelley, Global Director of Business Development – Informatics for Lonza.
About Lonza Bioscience – MODA-EM® solution
The MODA-EM® solution is a comprehensive platform for environmental, utility and product monitoring, combining automated scheduling, workflows, mobile data acquisition, device integration, and visual analytics. It eliminates paper-based monitoring and testing that can be expensive, error-prone, time and labour-intensive, therefore reducing timelines and potentially saving clients QC costs.
About Lonza:
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of CHF 3.8 billion in 2015 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
